ctrl K

AI Score

Unlock

Xilio Therapeutics Inc. (XLO)

AI Score

Unlock

0.88

-0.03 (-2.87%)

At close: Mar 03, 2025, 11:47 AM

Xilio Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.9M	1.85M	1.5M	1.06M	240K
Gross Profit	-1.9M	-1.85M	-1.5M	-1.06M	-240K
Operating Income	-79.13M	-89.15M	-75.04M	-54.56M	-19.03M
Interest Income	n/a	n/a	600.00	600.00	n/a
Pretax Income	-76.4M	-88.22M	-75.8M	-55.22M	-17.31M
Net Income	-76.4M	-87.3M	-74.3M	-55.22M	-17.31M
Selling & General & Admin	27M	29.95M	23.86M	10.65M	4.77M
Research & Development	52.14M	59.2M	51.19M	43.91M	14.26M
Other Expenses	n/a	927K	-756K	-656K	1.72M
Operating Expenses	79.13M	89.15M	75.04M	54.56M	19.03M
Interest Expense	n/a	n/a	600K	600K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	79.13M	89.15M	75.04M	54.56M	19.03M
Income Tax	n/a	-927K	-1.5M	858.7K	68.14K
Shares Outstanding (Basic)	27.5M	27.39M	27.36M	27.47M	27.47B
Shares Outstanding (Diluted)	27.5M	27.39M	27.36M	27.47M	27.47B
EPS (Basic)	-2.78	-3.19	-2.72	-2.01	-0.00
EPS (Diluted)	-2.78	-3.19	-2.72	-2.01	-0.00
EBITDA	-73.8M	-85.58M	-73.7M	-53.5M	-17.07M
Depreciation & Amortization	1.9M	1.85M	1.5M	1.06M	240K